Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


18.02.2019

1 Acta Ophthalmol
1 Am J Manag Care
1 Am J Ophthalmol
1 Biochem Biophys Res Commun
1 BMJ
2 Diabet Med
4 Diabetes
12 Diabetes Care
3 Diabetes Educ
10 Diabetes Obes Metab
2 Diabetologia
1 J Clin Invest
1 J Diabetes Complications
1 Lancet
1 Lancet Diabetes Endocrinol
1 Nature
5 Pediatr Diabetes
4 PLoS One
1 Transplant Proc


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Ophthalmol

  1. COMET A, Gascon P, Sauvan L, Donnadieu B, et al
    INVICTUS: intravitreal anti-VEGF and dexamethasone implant comparison for the treatment of diabetic macular edema: a 6 months follow-up Study.
    Acta Ophthalmol. 2019 Feb 11. doi: 10.1111/aos.14057.
    PubMed     Text format    


    Am J Manag Care

  2. WICKE FS, Glushan A, Schubert I, Koster I, et al
    Performance of the adapted Diabetes Complications Severity Index translated to ICD-10.
    Am J Manag Care. 2019;25:e45-e49.
    PubMed     Text format     Abstract available


    Am J Ophthalmol

  3. TAIPALE C, Ilveskoski L, Danni R, Tuuminen R, et al
    Diabetes Alone Does Not Impair Recovery From Uneventful Cataract Surgery.
    Am J Ophthalmol. 2019 Feb 8. pii: S0002-9394(19)30017.
    PubMed     Text format    


    Biochem Biophys Res Commun

  4. MOU Z, Feng Z, Xu Z, Zhuang F, et al
    Corrigendum to "Schisandrin B alleviates diabetic nephropathy through suppressing excessive inflammation and oxidative stress" Biochem. Biophys. Res. Commun. 508 (2019): 243-249.
    Biochem Biophys Res Commun. 2019 Feb 12. pii: S0006-291X(19)30214.
    PubMed     Text format    


    BMJ

  5. FEINMANN J
    Australian MPs visit Southport GP to learn about low carb diet for type 2 diabetes.
    BMJ. 2019;364:l659.
    PubMed     Text format    


    Diabet Med

  6. OLIVER N, Holt RIG
    The James Lind Alliance research priorities for diabetes.
    Diabet Med. 2019;36:267-268.
    PubMed     Text format    

  7. STAHL-PEHE A, Glaubitz L, Bachle C, Lange K, et al
    Diabetes distress in young adults with early-onset Type 1 diabetes and its prospective relationship with HbA1c and health status.
    Diabet Med. 2019 Feb 14. doi: 10.1111/dme.13931.
    PubMed     Text format     Abstract available


    Diabetes

  8. FIDLER TP, Marti A, Gerth K, Middleton EA, et al
    Glucose Metabolism is Required for Platelet Hyperactivation in a Murine Model of Type 1 Diabetes Mellitus.
    Diabetes. 2019 Feb 14. pii: db18-0981. doi: 10.2337/db18-0981.
    PubMed     Text format     Abstract available

  9. OH E, Ahn M, Afelik S, Becker TC, et al
    Syntaxin 4 Expression in Pancreatic beta-Cells Promotes Islet Function and Protects Functional beta-Cell Mass.
    Diabetes. 2018;67:2626-2639.
    PubMed     Text format     Abstract available

  10. MYERS MG JR.,
    Diabetes Takes New Steps to Increase Transparency and Reproducibility.
    Diabetes. 2019 Feb 11. pii: dbi19-0008. doi: 10.2337/dbi19-0008.
    PubMed     Text format    

  11. YUAN J, Tan JT, Rajamani K, Solly EL, et al
    Fenofibrate Rescues Diabetes-Related Impairment of Ischemia-Mediated Angiogenesis by PPARalpha-Independent Modulation of Thioredoxin Interacting Protein.
    Diabetes. 2019 Feb 14. pii: db17-0926. doi: 10.2337/db17-0926.
    PubMed     Text format     Abstract available


    Diabetes Care

  12. TSUDA A, Ishimura E, Uedono H, Ochi A, et al
    Association of Albuminuria With Intraglomerular Hydrostatic Pressure and Insulin Resistance in Subjects With Impaired Fasting Glucose and/or Impaired Glucose Tolerance.
    Diabetes Care. 2018;41:2414-2420.
    PubMed     Text format     Abstract available

  13. BERGENSTAL RM, Beck RW, Close KL, Grunberger G, et al
    Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring.
    Diabetes Care. 2018;41:2275-2280.
    PubMed     Text format     Abstract available

  14. EDELMAN SV, Argento NB, Pettus J, Hirsch IB, et al
    Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose Monitoring.
    Diabetes Care. 2018;41:2265-2274.
    PubMed     Text format     Abstract available

  15. SAKAMOTO M, Matsutani D, Minato S, Tsujimoto Y, et al
    Seasonal Variations in the Achievement of Guideline Targets for HbA1c, Blood Pressure, and Cholesterol Among Type 2 Diabetic Patients: A Nationwide Population-Based Study (ABC study) (JDDM49).
    Diabetes Care. 2019 Feb 10. pii: dc18-1953. doi: 10.2337/dc18-1953.
    PubMed     Text format     Abstract available

  16. LAW GR, Alnaji A, Alrefaii L, Endersby D, et al
    Suboptimal Nocturnal Glucose Control Is Associated With Large for Gestational Age in Treated Gestational Diabetes Mellitus.
    Diabetes Care. 2019 Feb 14. pii: dc18-2212. doi: 10.2337/dc18-2212.
    PubMed     Text format     Abstract available

  17. ZHANG X, Young RL, Bound M, Hu S, et al
    Comparative Effects of Proximal and Distal Small Intestinal Glucose Exposure on Glycemia, Incretin Hormone Secretion, and the Incretin Effect in Health and Type 2 Diabetes.
    Diabetes Care. 2019 Feb 14. pii: dc18-2156. doi: 10.2337/dc18-2156.
    PubMed     Text format     Abstract available

  18. HANSEN UM, Skinner T, Olesen K, Willaing I, et al
    Diabetes Distress, Intentional Hyperglycemia at Work, and Glycemic Control Among Workers With Type 1 Diabetes.
    Diabetes Care. 2019 Feb 14. pii: dc18-1426. doi: 10.2337/dc18-1426.
    PubMed     Text format     Abstract available

  19. CERIELLO A, Rossi MC, De Cosmo S, Lucisano G, et al
    Overall Quality of Care Predicts the Variability of Key Risk Factors for Complications in Type 2 Diabetes: An Observational, Longitudinal Retrospective Study.
    Diabetes Care. 2019 Feb 14. pii: dc18-1471. doi: 10.2337/dc18-1471.
    PubMed     Text format     Abstract available

  20. TSENG E, Dalcin AT, Jerome GJ, Gennusa JV, et al
    Effect of a Behavioral Weight Loss Intervention in People With Serious Mental Illness and Diabetes.
    Diabetes Care. 2019 Feb 14. pii: dc18-2201. doi: 10.2337/dc18-2201.
    PubMed     Text format     Abstract available

  21. COEMANS M, Van Loon E, Lerut E, Gillard P, et al
    Occurrence of Diabetic Nephropathy After Renal Transplantation Despite Intensive Glycemic Control: An Observational Cohort Study.
    Diabetes Care. 2019 Feb 14. pii: dc18-1936. doi: 10.2337/dc18-1936.
    PubMed     Text format     Abstract available

  22. MORGAN ES, Tai LJ, Pham NC, Overman JK, et al
    Antisense Inhibition of Glucagon Receptor by IONIS-GCGRRx Improves Type 2 Diabetes Without Increase in Hepatic Glycogen Content in Patients With Type 2 Diabetes on Stable Metformin Therapy.
    Diabetes Care. 2019 Feb 14. pii: dc18-1343. doi: 10.2337/dc18-1343.
    PubMed     Text format     Abstract available

  23. VERBRAAK FD, Abramoff MD, Bausch GCF, Klaver C, et al
    Diagnostic Accuracy of a Device for the Automated Detection of Diabetic Retinopathy in a Primary Care Setting.
    Diabetes Care. 2019 Feb 14. pii: dc18-0148. doi: 10.2337/dc18-0148.
    PubMed     Text format     Abstract available


    Diabetes Educ

  24. ABDOLI S, Jones DH, Vora A, Stuckey H, et al
    Improving Diabetes Care: Should We Reconceptualize Diabetes Burnout?
    Diabetes Educ. 2019 Feb 9:145721719829066. doi: 10.1177/0145721719829066.
    PubMed     Text format     Abstract available

  25. MCEWEN MM, Pasvogel A, Elizondo-Pereo R, Meester I, et al
    Diabetes Self-Management Behaviors, Health Care Access, and Health Perception in Mexico-US Border States.
    Diabetes Educ. 2019 Feb 10:145721719828952. doi: 10.1177/0145721719828952.
    PubMed     Text format     Abstract available

  26. DINARDO MM, Sereika SM, Korytkowski M, Baniak LM, et al
    Current Smoking: An Independent Predictor of Elevated A1C in Persons With Type 2 Diabetes.
    Diabetes Educ. 2019 Feb 12:145721719829068. doi: 10.1177/0145721719829068.
    PubMed     Text format     Abstract available


    Diabetes Obes Metab

  27. TUTTLE KR, Lakshmanan MC, Rayner B, Zimmermann AG, et al
    Body Weight and eGFR during Dulaglutide Treatment in Type 2 Diabetes and Moderate-to-Severe Chronic Kidney Disease (AWARD-7).
    Diabetes Obes Metab. 2019 Feb 14. doi: 10.1111/dom.13668.
    PubMed     Text format     Abstract available

  28. LYTVYN Y, Bjornstad P, Lovshin JA, Singh SK, et al
    The Association Between Uric Acid, Renal Hemodynamics and Arterial Stiffness Over the Natural History of Type 1 Diabetes.
    Diabetes Obes Metab. 2019 Feb 13. doi: 10.1111/dom.13665.
    PubMed     Text format     Abstract available

  29. PHILIS-TSIMIKAS A, Billings LK, Busch R, Morales Portillo C, et al
    Superior Efficacy of Insulin Degludec/Liraglutide versus Insulin Glargine U100 as Add-on to Sodium-Glucose Co-Transporter-2 Inhibitor Therapy: a Randomized Clinical Trial in Patients with Uncontrolled Type 2 Diabetes.
    Diabetes Obes Metab. 2019 Feb 13. doi: 10.1111/dom.13666.
    PubMed     Text format     Abstract available

  30. LEE DH, Chun EJ, Oh TJ, Kim KM, et al
    Effect of Cilostazol, a Phosphodiesterase-3 Inhibitor, on Coronary Artery Stenosis and Plaque Characteristics in Patients with Type 2 Diabetes (ESCAPE Study).
    Diabetes Obes Metab. 2019 Feb 13. doi: 10.1111/dom.13667.
    PubMed     Text format     Abstract available

  31. PARKINSON J, Tang W, Astrand M, Melin J, et al
    Model-based characterization of the relationship between dapagliflozin systemic exposure and HbA1c response in patients with type 1 diabetes mellitus.
    Diabetes Obes Metab. 2019 Feb 12. doi: 10.1111/dom.13664.
    PubMed     Text format     Abstract available

  32. CANIVELL S, Mata-Cases M, Real J, Franch-Nadal J, et al
    Glycemic Control after Treatment Intensification in Patients with Type 2 Diabetes Uncontrolled on Two or More Non-Insulin Antidiabetic Drugs in a Real-World Setting.
    Diabetes Obes Metab. 2019 Feb 12. doi: 10.1111/dom.13663.
    PubMed     Text format     Abstract available

  33. MEZQUITA RAYA P, Ampudia Blasco FJ, Hunt B, Martin V, et al
    Evaluating the Long-Term Cost-Effectiveness of ideglira for type 2 diabetes in spain based on Real-World clinical evidence.
    Diabetes Obes Metab. 2019 Feb 11. doi: 10.1111/dom.13660.
    PubMed     Text format     Abstract available

  34. FUECHTENBUSCH M, Aberle J, Heitmann E, Nicolay C, et al
    Weight loss in patients with type 2 diabetes (T2D) mellitus receiving once-weekly dulaglutide plus insulin lispro or insulin glargine plus insulin lispro: An AWARD-4 post-hoc analysis across baseline body mass index subgroups.
    Diabetes Obes Metab. 2019 Feb 8. doi: 10.1111/dom.13658.
    PubMed     Text format     Abstract available

  35. JOHNSTON SS, Ammann EM, Kashyap SR, Stokes A, et al
    Body Mass Index and Insulin Use as Identifiers of High-Cost Patients with Type 2 Diabetes: A Retrospective Analysis of Electronic Health Records Linked to Insurance Claims Data.
    Diabetes Obes Metab. 2019 Feb 15. doi: 10.1111/dom.13671.
    PubMed     Text format     Abstract available

  36. MENEGHINI LF, Mauricio D, Orsi E, Lalic NM, et al
    The Diabetes Unmet Need with basal insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real-world setting.
    Diabetes Obes Metab. 2019 Feb 15. doi: 10.1111/dom.13673.
    PubMed     Text format     Abstract available


    Diabetologia

  37. ORAM RA, Sims EK, Evans-Molina C
    Beta cells in type 1 diabetes: mass and function; sleeping or dead?
    Diabetologia. 2019 Feb 14. pii: 10.1007/s00125-019-4822.
    PubMed     Text format     Abstract available

  38. STENVERS DJ, Jongejan A, Atiqi S, Vreijling JP, et al
    Diurnal rhythms in the white adipose tissue transcriptome are disturbed in obese individuals with type 2 diabetes compared with lean control individuals.
    Diabetologia. 2019 Feb 9. pii: 10.1007/s00125-019-4813.
    PubMed     Text format     Abstract available


    J Clin Invest

  39. LI Y, Hu Q, Li C, Liang K, et al
    PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney disease.
    J Clin Invest. 2019 Feb 11. pii: 121987. doi: 10.1172/JCI121987.
    PubMed     Text format     Abstract available


    J Diabetes Complications

  40. DEDINSKA I, Granak K, Vnucak M, Skalova P, et al
    Role of sex in post-transplant diabetes mellitus development: Are men and women equal?
    J Diabetes Complications. 2019 Jan 4. pii: S1056-8727(18)31161.
    PubMed     Text format     Abstract available


    Lancet

  41. UNAMUNO X, Fruhbeck G
    Lorcaserin: balancing efficacy with potential risks.
    Lancet. 2018;392:2239-2240.
    PubMed     Text format    


    Lancet Diabetes Endocrinol

  42. SATHISH T
    Diabetes prevention and lifestyle intervention in resource-limited settings.
    Lancet Diabetes Endocrinol. 2019 Feb 5. pii: S2213-8587(19)30027.
    PubMed     Text format    


    Nature

  43. FURUYAMA K, Chera S, van Gurp L, Oropeza D, et al
    Diabetes relief in mice by glucose-sensing insulin-secreting human alpha-cells.
    Nature. 2019 Feb 13. pii: 10.1038/s41586-019-0942.
    PubMed     Text format     Abstract available


    Pediatr Diabetes

  44. TOWNSON J, Cannings-John R, Francis N, Thayer D, et al
    Presentation to primary care during the prodrome of Type 1 diabetes in childhood: a case-control study using record data linkage.
    Pediatr Diabetes. 2019 Feb 9. doi: 10.1111/pedi.12829.
    PubMed     Text format     Abstract available

  45. TELO GH, Cureau FV, Szklo M, Bloch KV, et al
    Prevalence of type 2 diabetes among adolescents in Brazil: findings from Study of Cardiovascular Risk in Adolescents (ERICA).
    Pediatr Diabetes. 2019 Feb 9. doi: 10.1111/pedi.12828.
    PubMed     Text format     Abstract available

  46. PRINZ N, Zolin A, Konrad K, Nahrlich L, et al
    Characteristics of CF-related Diabetes: Data from Two Different Sources the ECFS Patient Registry and the DPV Registry.
    Pediatr Diabetes. 2019 Feb 13. doi: 10.1111/pedi.12831.
    PubMed     Text format     Abstract available

  47. PUNALES M, Marilia Dornelles Bastos M, Ramos ARL, Pinto RRB, et al
    Prevalence of celiac disease in a large cohort of young patients with type 1 diabetes.
    Pediatr Diabetes. 2019 Feb 8. doi: 10.1111/pedi.12827.
    PubMed     Text format     Abstract available

  48. THIELE AG, Heckenmuller M, Bartelt H, Klamt S, et al
    Review of Leipzig protocol for intravenous insulin infusion in pediatric patients with type 1 diabetes during intercurrent illness and surgery.
    Pediatr Diabetes. 2019 Feb 13. doi: 10.1111/pedi.12830.
    PubMed     Text format     Abstract available


    PLoS One

  49. CHEN J, Jing X, Liu X, Volkmann AM, et al
    Assessment of factors affecting diabetes management in the City Changing Diabetes (CCD) study in Tianjin.
    PLoS One. 2019;14:e0209222.
    PubMed     Text format     Abstract available

  50. DIETER BP, Meek RL, Anderberg RJ, Cooney SK, et al
    Serum amyloid A and Janus kinase 2 in a mouse model of diabetic kidney disease.
    PLoS One. 2019;14:e0211555.
    PubMed     Text format     Abstract available

  51. VAN DER DONK LJ, Fleer J, Sanderman R, Emmelkamp PMG, et al
    Is type of depressive symptoms associated with patient-perceived need for professional psychological care in depressed individuals with diabetes?
    PLoS One. 2019;14:e0212304.
    PubMed     Text format     Abstract available

  52. XU Y, Pilla SJ, Alexander GC, Murimi IB, et al
    Use of non-insulin diabetes medicines after insulin initiation: A retrospective cohort study.
    PLoS One. 2019;14:e0211820.
    PubMed     Text format     Abstract available


    Transplant Proc

  53. KLEINSTEUBER A, Halleck F, Khadzhynov D, Staeck A, et al
    Impact of Pre-existing Comorbidities on Long-term Outcomes in Kidney Transplant Recipients.
    Transplant Proc. 2018;50:3232-3241.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: